Vitroscope

Vitroscope builds automated perfusion platforms that keep living human tissue and organoids alive under controlled flow. Its benchtop vitro.alive runs six parallel experiments, and a 96-experiment version is planned for 2028. In November 2026 it raised $7 million, including $2 million from the Research Council of Norway.